Biotechnology / Investing / Resources / Venture capital

5 noteworthy Baltimore-area investment deals from Q2 2015

The latest MoneyTree Report shows growth in venture capital investment in Maryland-based companies — but one deal in biotech drove most of the action.

Members of Avhana Health, which raised $750,000 in June 2015. (Courtesy photo)

The second three months of 2015 brought a 30 percent increase in venture capital deals nationwide, with software companies seeing the biggest investment to the tune of $7.3 billion.
Maryland mirrored the first part of that trend, but continues to see biotech leading the pace in the industry space.
According to data released in the quarterly MoneyTree Report from PricewaterhouseCoopers and the National Venture Capital Association, the second quarter of 2015 saw a $25 million increase in the amount of money invested in Maryland-based companies, with about $137 million put up by VCs.
The bulk of that money was in the biotech space, where $88 million was invested.
Specifically, it was in one $70 million deal landed by Rockville-based gene therapy company Regenxbio. Consumer products and services was the second-highest investment category, bolstered by a $16 million deal for Rockville-based restaurant operator C.A.V.A.
Software was down significantly after posting a $39 million first quarter, but a $3 million round for Baltimore-based 6th Street led the way.
Here are 5 Baltimore-area deals of note for the second quarter, with links to our prior stories:

Companies: Regenxbio / Avhana Health / 6th Street Inc. / PricewaterhouseCoopers

Knowledge is power!

Subscribe for free today and stay up to date with news and tips you need to grow your career and connect with our vibrant tech community.

Technically Media